The global nephrology and urology incontinence devices market is set to experience steady growth, with its valuation projected to rise from USD 38 billion in 2021 to USD 46.4 billion by 2026, at a CAGR of 4.1% over the forecast period. This growth is fueled by the increasing prevalence of urinary incontinence disorders, rising geriatric population, and technological advancements in medical devices.
The growing number of individuals suffering from bladder control issues and related urinary system disorders has resulted in a strong demand for nephrology and urology incontinence devices. The elderly population is particularly vulnerable to such conditions, leading to higher adoption rates of these devices in nursing homes, hospitals, and personal care settings.
Furthermore, advances in incontinence device technology are reshaping the industry landscape. Devices are becoming more discreet, comfortable, and user-friendly, driving patient acceptance and boosting demand. The development of wearable, sensor-enabled devices for real-time monitoring of bladder activity is also opening new opportunities in the market.
Healthcare providers are placing greater emphasis on patient dignity and independence, encouraging the use of advanced urology devices that allow patients to maintain a higher quality of life. As governments and healthcare institutions raise awareness about the availability of modern solutions, the adoption of non-invasive and minimally invasive treatments is set to increase.
A Full Report Overview – https://www.futuremarketinsights.com/reports/nephrology-and-urology-incontinence-devices-market
Key Takeaways:
- The nephrology and urology incontinence devices market is forecasted to grow from USD 38 billion in 2021 to USD 46.4 billion by 2026, reflecting a CAGR of 4.1% over the forecast period.
- Growth is fueled by the rising prevalence of urinary incontinence disorders, particularly among the aging population.
- Technological advancements are driving the development of more comfortable, discreet, and sensor-enabled incontinence devices, boosting patient adoption.
- The growing focus on non-invasive and minimally invasive treatment options is encouraging healthcare providers to opt for advanced urology devices, ensuring better patient outcomes.
- Wearable and connected devices with real-time monitoring capabilities are expected to be a game-changer in the market, offering enhanced comfort and ease of use.
The rising need for effective incontinence management solutions is pushing healthcare providers and device manufacturers to develop customized, patient-friendly solutions. As healthcare awareness grows and technological innovations continue to shape the market, the nephrology and urology incontinence devices sector is expected to witness steady growth through 2026.
Market Overview
The growth of the nephrology and urology incontinence devices market is driven by several key factors:
- Increasing Prevalence of Chronic Kidney and Urological Diseases: The rising incidence of conditions such as chronic kidney disease (CKD), benign prostatic hyperplasia, and urinary incontinence is significantly contributing to the demand for incontinence devices.
- Aging Population: An increasing elderly population, which is more susceptible to urinary disorders, is driving the need for effective management solutions.
- Technological Advancements: Innovations in device design and materials are enhancing the effectiveness and comfort of incontinence products, leading to higher adoption rates among patients.
- Growing Awareness and Acceptance: Increased awareness about urinary incontinence and the availability of various treatment options are encouraging more individuals to seek help and use incontinence devices.
- Investment in Healthcare Infrastructure: Expanding healthcare facilities, particularly in developing regions, are improving access to nephrology and urology services, thereby boosting the demand for related devices.
Who are the Key Players in the Nephrology and Urology Incontinence Devices Market?
Some of the key participating players in the nephrology and urology incontinence devices market are Baxter International Inc., C. R. Bard, Inc, Coloplast UK Ltd., Unicharm Corporation., Kimberly-Clark Corporation, Hollister Inc., ConvaTec, B.Braun Melsungen AG, SCA (Svenska Cellulosa Aktiebolaget) and others.
Increased demand for nephrology and urology incontinence devices is predicted to rise due to a growing desire for minimally invasive and non-invasive treatment approaches.
Recent Developments
- The FDA granted Baxter International Inc. (US) 510(k) certification for their Homechoice Claria automated peritoneal dialysis system with the Sharesource connection platform in November 2020.
- In May of this year, Fresenius Medical Care AG & Co. KGaA (Germany) announced the opening of a new distribution facility in Knoxville, Tennessee. This extension will make it easier to get goods for in-center hemodialysis therapy.
- Fresenius Medical Care AG & Co. KGaA (Germany) bought NxStage Medical, Inc. (US) in February 2019 to expand its renal and critical care product range.
Key Companies Profiled
Baxter International Inc.; C. R. Bard, Inc.; Coloplast UK Ltd.; Unicharm Corporation; Kimerly-Clark Corporation; Hollister Inc.; ConvaTec; B.Braun Melsungen AG; SCA (Svenska Cellulosa Aktiebolaget)
Key Segments
By Type:
- Dialysis Devices and Equipment
- Urinary Stone Treatment Devices and Equipment
- Urinary Incontinence & Pelvic Organ Prolapse Devices and Equipment
- Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment
- Endoscopy Devices and Equipment
By End User:
- Hospitals and Clinics
- Diagnostic Laboratories
By Type Of Expenditure:
- Public
- Private
By Product:
- Instruments/Equipment
- Disposables
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Poultry Diagnostic Testing Market
Helicobacter Pylori Testing Market
Head Band Ophthalmoscopes Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube